The diagnostic and predictive potential of lncRNA CASC2 targeting miR-155 in systemic lupus erythematosus patients with nephritis complication
2024

CASC2 and miR-155 as Biomarkers in Lupus Nephritis

Sample size: 60 publication 10 minutes Evidence: high

Author Information

Author(s): Mohamed Nada R., El-Fattah Abeer l. Abd, Shaker Olfat, Sayed Ghadir A

Primary Institution: Egyptian Russian University

Hypothesis

This research investigates lncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers in SLE patients, including those with and without nephritis.

Conclusion

Both lncRNA CASC2 and miR-155 could serve as valuable non-invasive diagnostic biomarkers for SLE and predicting lupus nephritis.

Supporting Evidence

  • Increased levels of lncRNA CASC2 were observed in SLE patients compared to healthy controls.
  • Elevated expression of lncRNA CASC2 was correlated with the severity of the disease.
  • MiR-155 was down-regulated in SLE patients relative to controls.

Takeaway

This study found that two molecules in the blood can help doctors tell if someone has a serious kidney problem related to lupus.

Methodology

The study involved measuring lncRNA CASC2 and miR-155 levels in serum samples from SLE patients and healthy controls using real-time PCR.

Limitations

The modest sample size may constrain the statistical power of the study.

Participant Demographics

60 SLE patients aged 18-60, including 30 with lupus nephritis and 30 without, plus 30 healthy controls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41598-024-81212-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication